ForteBio Launches Dip and Readâ„¢ Anti-Human Fab-CH1 Biosensor to Accelerate Human Biotherapeutic Drug Development

[at noodls] – PORT WASHINGTON, N.Y., January 09, 2013 – ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical … more

View todays social media effects on PLL

View the latest stocks trending across Twitter. Click to view dashboard

See who Pall is hiring next, click here to view